127:
neuropsychiatric disorders in order to accelerate the discovery and development of better treatments for patients with those disorders. The ability to precisely link neuropsychiatric symptoms to underlying neurobiology will not only facilitate the development of better treatments, it will also allow physicians to provide patients with a better understanding of the complexities and management of their illness.
134:(ECNP), the largest European organization for neuroscience applied research. ECNP provides a platform for interactions between scientists, patients and their families, pharmaceutical industry and regulators for optimizing the treatment of brain disorders, and organizes many activities, including an annual congress with 4500-6000 participants.
126:
at the
Groningen Institute for Evolutionary Life Sciences, University of Groningen, the Netherlands, where he leads a research group entitled "Behavioural Neuroscience". His research aims to develop a quantitative, transdiagnostic and translational neurobiological approach to the understanding of
243:
as principal investigator. He received a VIDI grant as principal investigator on a project studying interspecies genetics of neurobehavioral traits in mice and men. As project coordinator he was awarded the
182:. He completed a postdoctoral fellowship at the University Medical Center Utrecht and was a visiting scientist at the Social, Genetic and Developmental Psychiatry Research Centre at the
231:
Kas is currently serving as
President of the European College of Neuropsychopharmacology (ECNP) for the term 2022-2025, having previously served as Secretary and Councilor.
304:
314:
131:
309:
199:
253:
245:
299:
319:
163:
225:
85:
183:
179:
171:
95:
52:
294:
240:
289:
191:
175:
48:
155:
269:
205:
208:
of neurobehavioral traits (in mice and humans), Kas' research aims to identify functional
283:
221:
195:
151:
103:
249:
213:
123:
99:
217:
209:
159:
119:
147:
187:
167:
143:
70:
Marie Curie
Fellowship, VIDI grant, Innovative Medicine Initiative
257:
256:
62:
Translational and transdiagnostic neuroscience research
91:
81:
66:
58:
43:
25:
18:
220:-directed treatment of brain disorders, such as
216:relationships relevant to the development and
268:Kas has published extensively, with numerous
8:
132:European College of Neuropsychopharmacology
15:
198:, Brain Center Rudolf Magnus, at the
7:
305:Academic staff of Utrecht University
315:Vrije Universiteit Amsterdam alumni
47:Ph.D. in Behavioral Neuroscience,
14:
200:University Medical Center Utrecht
130:He is currently President of the
272:and book chapters to his name.
254:Innovative Medicines Initiative
246:Innovative Medicines Initiative
310:University of Groningen alumni
1:
164:Vrije Universiteit Amsterdam
336:
196:Translational Neuroscience
226:autism spectrum disorders
204:By applying interspecies
150:, with specialization in
109:
74:
118:(born 27 November 1966,
86:Behavioural Neuroscience
184:Institute of Psychiatry
180:University of Groningen
172:behavioral neuroscience
96:University of Groningen
53:University of Groningen
270:peer-reviewed articles
241:Marie Curie Fellowship
300:Dutch neuroscientists
252:, and co-awarded the
194:in the Department of
320:People from Uithoorn
239:Kas has received a
192:associate professor
176:Stanford University
49:Stanford University
156:psychopharmacology
142:Kas received his
116:Martien J. H. Kas
113:
112:
76:Scientific career
327:
206:genetic analysis
39:
36:27 November 1966
35:
33:
16:
335:
334:
330:
329:
328:
326:
325:
324:
280:
279:
278:
266:
250:PRISM2 projects
237:
140:
37:
31:
29:
21:
12:
11:
5:
333:
331:
323:
322:
317:
312:
307:
302:
297:
292:
282:
281:
277:
274:
265:
262:
236:
233:
139:
136:
111:
110:
107:
106:
93:
89:
88:
83:
79:
78:
72:
71:
68:
64:
63:
60:
59:Known for
56:
55:
45:
41:
40:
27:
23:
22:
19:
13:
10:
9:
6:
4:
3:
2:
332:
321:
318:
316:
313:
311:
308:
306:
303:
301:
298:
296:
295:Living people
293:
291:
288:
287:
285:
275:
273:
271:
263:
261:
259:
258:Aims-2-trials
255:
251:
247:
242:
234:
232:
229:
227:
223:
222:schizophrenia
219:
215:
211:
207:
202:
201:
197:
193:
190:). He was an
189:
185:
181:
177:
173:
169:
165:
161:
157:
153:
149:
145:
137:
135:
133:
128:
125:
121:
117:
108:
105:
101:
97:
94:
90:
87:
84:
80:
77:
73:
69:
65:
61:
57:
54:
50:
46:
42:
38:(age 57)
28:
24:
17:
267:
264:Publications
238:
230:
203:
152:neurobiology
141:
129:
115:
114:
92:Institutions
75:
290:1966 births
248:PRISM1 and
104:Netherlands
20:Martien Kas
284:Categories
276:References
32:1966-11-27
214:phenotype
162:from the
124:professor
100:Groningen
44:Education
218:etiology
210:genotype
178:and the
166:, and a
160:ethology
120:Uithoorn
148:biology
235:Honors
188:London
158:, and
138:Career
82:Fields
67:Awards
174:from
168:Ph.D.
144:M.Sc.
122:) is
224:and
26:Born
170:in
146:in
286::
260:.
228:.
154:,
102:,
98:,
34:)
212:–
186:(
51:/
30:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.